WORLD
A Summit on the Nascent Domain of Behavioural TelehealthThe inaugural summit on Behavioral Telehealth: Technology for Behavior Change & Disease […]
Say something
A Summit on the Nascent Domain of Behavioural TelehealthThe inaugural summit on Behavioral Telehealth: Technology for Behavior Change & Disease […]
Indegene Lifesystems Pvt Ltd., a scientific partner to global pharmaceutical and life sciences companies, today highlighted the benefits its pharmaceutical clients are reaping through comprehensive and multichannel patient support and adherence programs.
Prometheus Laboratories Inc, a specialty pharmaceutical and diagnostic company, announced that it has entered into a definitive agreement to be acquired by Nestl
Indegene Lifesystems Pvt Ltd, a scientific partner to global pharmaceutical and life sciences companies, today announced that it has won seven awards at the prestigious Hermes Creative Awards 2011.
Pharma RFID market expected to hit US$ 1 trillion by 2020 The market for Radio Frequency Identification (RFID) applications in […]
Recent analysis shows that the high priced research and development companies which show $1.3 billion cost are not real.
The FCCB holders, funded by QVT, Sun Pharma and Syndicate Bank, hold bonds worth $42 million in a pharmaceutical company Wockhardt Ltd.
The industry department is about to finalise the terms under which the government can order the manufacture of drugs without seeking the permission of the patent holder by the end of this month.
Pfizer loses $10-billion-a-year revenue in November this year as its major cholesterol drug Lipitor patent expires.
Indian drug makers are now tapping their feet to become the world
As the Vice President and General Manager of Quest Diagnostics, Dr Sumit Dutta is responsible for creating an environment of quality, integrity and success for patients, customers and employees. Today, Quest Diagnostics is one of the largest pathology laboratories in the world.
A new cancer treatment which strengthens a patient’s immune system and enables them to fight the disease more effectively is being trialled on patients for the first time in the UK.
Researchers have developed a new biochip technology, which could soon put a stop to the use of animals for testing in the chemical and cosmetics industries.